December 11, 2020
December 11, 2020 - The U.S. Food and Drug Administration (FDA) granted Pfizer and BioNTech an
Emergency Use Authorization (EUA) for the companies’ jointly developed COVID-19 vaccine.
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global Reach Health News
December 9, 2020
December 9, 2020 – AvKARE of Pulaski, TN, has voluntarily recalled one lot of Sildenafil 100mg tablets and
one lot of Trazodone 100mg tablets after the two products were inadvertently packaged
December 9, 2020
December 9, 2020 – Torrent Pharmaceuticals has voluntarily recalled one lot of Anagrelide Capsules, USP, following the product’s failure in a dissolution test that is part of routine quality testing.
December 4, 2020
December 4, 2020 –The U.S. FDA has approved a label update for Merck’s Januvia® (sitagliptin), Janumet®
(sitagliptin/metformin hydrochloride), and Janumet® XR (sitagliptin/metformin
December 4, 2020
December 4, 2020 – The U.S. FDA has approved an expanded indication for Saxenda® (liraglutide) injection 3mg, manufactured by Novo Nordisk. First FDA approved in 2014 to provide chronic weight
December 3, 2020
December 3, 2020 – The U.S. FDA has approved OrladeyoTM (berotralstat), manufactured by BioCryst Pharmaceuticals, to provide prophylaxis (prevention) of hereditary angioedema (HAE)
December 1, 2020
December 1, 2020 – The U.S. FDA has approved two new indications for GavretoTM (pralsetinib),
manufactured by Roche and Blueprint Medicines, to treat certain types of thyroid cancer.
December 1, 2020
December 1, 2020 – The U.S. FDA has approved a new indication for Xolair® (omalizumab), manufactured by Genentech. The drug is now indicated for use as an add-on maintenance treatment